David E. Olson

David E. Olson, founding director of the UC Davis Institute of Psychedelics and Neurotherapeutics, discusses the potential of developing non-hallucinogenic psychedelics for mental health treatment. The podcast explores the therapeutic effects of psychedelics on neuropsychiatric diseases and the need for rapid and effective treatments. The development of novel compounds called cycloplastogens, which promote neuronal growth, is also discussed along with the accessibility of psychedelic therapies and clinical trials.